Home > Healthcare > Drug Device Combination > Therapeutic Systems > Medical Biomimetics Market
Medical Biomimetics Market Size
- Report ID: GMI767
- Published Date: Aug 2021
- Report Format: PDF
Medical Biomimetics Market Size
Medical Biomimetics Market size was valued at over USD 32 billion in 2020 and is expected to witness more than 6.5% CAGR from 2021 to 2027. Advancements in biomimetics development technologies have improved its potential in basic research and clinical applications. Innovations and adoption of nanotechnology and medical engineering in healthcare leads to access numerous applications such as tissue engineering, plastic surgery, organ regeneration, implants, and drug delivery among others. With growing effectiveness in treatment and recovery using biomimetic products, the industry will observe lucrative growth during the forecast timeframe.
Rising prevalence rate of chronic disease will augment the market demand in the coming years. Geriatric population is highly susceptible to several diseases such as neurological diseases, cardiovascular diseases, orthopedic diseases among several others. As per the National Kidney Foundation, one in five men and one in four women aged 65 to 74 years having chronic kidney disease in the world. Hence, increasing application of biomimetics to treat patients and use of nanotechnological platforms for better therapeutic outcomes will enhance the industry outlook during the forecast period.
| Report Attribute | Details |
|---|---|
| Base Year: | 2020 |
| Medical Biomimetics Market Size in 2020: | USD 32.2 Billion |
| Forecast Period: | 2021 to 2027 |
| Forecast Period 2021 to 2027 CAGR: | 6.5% |
| 2027 Value Projection: | USD 53.2 Billion |
| Historical Data for: | 2016 to 2020 |
| No. of Pages: | 130 |
| Tables, Charts & Figures: | 198 |
| Segments covered: | Product, Application, Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Medical Biomimetics Market Scope
